Cargando…

Rapid remission of minimal change disease with angiotensin II antagonist treatment in a type 1 diabetic patient with no diabetic nephropathy

Detalles Bibliográficos
Autores principales:	Takahashi, Naoki, Kimura, Hideki, Nishi, Shinichi, Yamamoto, Chie, Kawajiri, Yumiko, Makino, Yasukazu, Konoshita, Tadashi, Miyamori, Isamu, Yoshida, Haruyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2008
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421275/ https://www.ncbi.nlm.nih.gov/pubmed/25983943 http://dx.doi.org/10.1093/ndtplus/sfn047

Ejemplares similares

Genetic Variant of the Renin-Angiotensin System and Diabetes Influences Blood Pressure Response to Angiotensin Receptor Blockers
por: Konoshita, Tadashi, et al.
Publicado: (2009)

An association study of C9orf3, a novel component of the renin-angiotensin system, and hypertension in diabetes
por: Ichikawa, Mai, et al.
Publicado: (2020)

Combination therapy with an angiotensin‐converting‐enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy
por: Nakamura, Akihiko, et al.
Publicado: (2012)

Genetic variant of the renin-angiotensin system and prevalence of type 2 diabetes mellitus: a modest but significant effect of aldosterone synthase
por: Ichikawa, Mai, et al.
Publicado: (2014)

Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System–Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System
por: Konoshita, Tadashi
Publicado: (2011)

The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic  Nephropathy
por: Goenka, Luxitaa, et al.
Publicado: (2019)

Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
por: Ravid, Mordchai
Publicado: (2009)

Microinflammation in the pathogenesis of diabetic nephropathy
por: Shikata, Kenichi, et al.
Publicado: (2013)

Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy
por: Sun, Li‐Jing, et al.
Publicado: (2017)

A review of urinary angiotensin converting enzyme 2 in diabetes and diabetic nephropathy
por: Gilbert, Akankwasa, et al.
Publicado: (2018)

The Effects of Blocking Angiotensin Receptors on Early Stages of Diabetic Nephropathy
por: Gheissari, Alaleh, et al.
Publicado: (2012)

Advances in the Renin-Angiotensin-Aldosterone System: Relevance to Diabetic Nephropathy
por: Koitka, Audrey, et al.
Publicado: (2008)

Angiotensin converting enzyme gene polymorphism in type II diabetics with nephropathy
por: Naresh, V. V. S., et al.
Publicado: (2009)

Angiotensin converting enzyme gene polymorphism in type 2 diabetics with nephropathy
por: Naresh, V. V. S., et al.
Publicado: (2010)

Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
por: Lozano-Maneiro, Luz, et al.
Publicado: (2015)

Olmesartan is More Effective Than Other Angiotensin Receptor Antagonists in Reducing Proteinuria in Patients With Chronic Kidney Disease Other Than Diabetic Nephropathy()
por: Ono, Takashi, et al.
Publicado: (2013)

A new Classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy
por: Haneda, Masakazu, et al.
Publicado: (2015)

A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy
por: Pathak, Jahnavi V., et al.
Publicado: (2015)

Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy
por: Furuichi, Kengo, et al.
Publicado: (2020)

Hypopituitarism and Central Diabetes Insipidus Caused by Central Nervous System Lymphoma
por: Zenimaru, Yasuo, et al.
Publicado: (2018)

Randomized trial of an intensified, multifactorial intervention in patients with advanced‐stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT‐Japan)
por: Shikata, Kenichi, et al.
Publicado: (2020)

Emerging Therapies for Diabetic Nephropathy Patients: Beyond Blockade of the Renin-Angiotensin System
por: Tanios, Bassem Y., et al.
Publicado: (2012)

Oxidative Stress/Angiotensinogen/Renin-Angiotensin System Axis in Patients with Diabetic Nephropathy
por: Kamiyama, Masumi, et al.
Publicado: (2013)

Polymorphism of Angiotensin-Converting Enzyme (rs4340) and Diabetic Nephropathy in Caucasians with Type 2 Diabetes Mellitus
por: Šeruga, M, et al.
Publicado: (2016)

Aldosterone Antagonists in Monotherapy Are Protective against Streptozotocin-Induced Diabetic Nephropathy in Rats
por: Banki, Nora F., et al.
Publicado: (2012)

CMKLR1 Antagonist Alpha-NETA Protects against Diabetic Nephropathy in Mice
por: Peng, Zining, et al.
Publicado: (2023)

Renoprotective potential of concomittant medications with SGLT2 inhibitors and renin-angiotensin system inhibitors in diabetic nephropathy without albuminuria: a retrospective cohort study
por: Ishibashi, Tatsuya, et al.
Publicado: (2023)

Effects of adding tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy
por: Fang, Jin-Ying, et al.
Publicado: (2020)

Adiponectin retards the progression of diabetic nephropathy in db/db mice by counteracting angiotensin II
por: Guo, Xiaohua, et al.
Publicado: (2014)

MicroRNA in Diabetic Nephropathy: Renin Angiotensin, AGE/RAGE, and Oxidative Stress Pathway
por: Hagiwara, Shinji, et al.
Publicado: (2013)

Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy
por: Ding, Dan, et al.
Publicado: (2015)

Podocyte injury in diabetic nephropathy: implications of angiotensin II – dependent activation of TRPC channels
por: Ilatovskaya, Daria V., et al.
Publicado: (2015)

Intestinal dysbiosis activates renal renin-angiotensin system contributing to incipient diabetic nephropathy
por: Lu, Chen Chen, et al.
Publicado: (2018)

The Interplay of Renin-Angiotensin System and Toll-Like Receptor 4 in the Inflammation of Diabetic Nephropathy
por: Feng, Qi, et al.
Publicado: (2020)

Stimulation of Angiotensin Converting Enzyme 2: A Novel Treatment Strategy for Diabetic Nephropathy
por: Nomura, Haru, et al.
Publicado: (2022)

What is Diabetes Remission?
por: Holst, Jens J., et al.
Publicado: (2021)

Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review
por: Zhang, Li, et al.
Publicado: (2020)

Endothelin Receptor Antagonists as a Potential Treatment of Diabetic Nephropathy: A Systematic Review
por: Ahmad, Noorain, et al.
Publicado: (2021)

Dual Blockade of Renin Angiotensin System in Reducing the Early Changes of Diabetic Retinopathy and Nephropathy in a Diabetic Rat Model
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2014)

A Genetic Variant in the Distal Enhancer Region of the Human Renin Gene Affects Renin Expression
por: Makino, Yasukazu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3bctmbbioobb1srnavpa8pcjqb